New Delhi, July 24 -- Proposed steep tariffs by the United States on generic medicines could affect India's pharmaceutical exports, particularly to its largest overseas market, the Global Trade Research Initiative (GTRI) said on Wednesday. However, the think tank noted that the impact is likely to vary across product categories.

Limited Immediate Impact on Low-Cost Generics

GTRI noted, "Many Indian generic medicines sell for seven to ten times less than branded alternatives. Even after a 100 per cent tariff, many products could remain cheaper than branded medicines, meaning much of the additional cost would likely be passed on to US healthcare providers, insurers and patients rather than immediately eliminating Indian exports," PTI repo...